Monday, December 16, 2013

Global Markets for Orphan Drugs to reach $112.1 billion by 2017

The orphan drug market is one of the fastest-growing segments in the pharmaceutical and biotechnology industry. Extensive research in this field has resulted in biological and nonbiological therapeutic treatments for a number of rare diseases. Technological advances, new product launches, and increasing assistance from regulatory bodies will spur steady growth in this market for foreseeable future.

BCC Research provides an in-depth analysis of the global orphan drugs market through its report Global Markets for Orphan Drugs. According to the report, this market was valued at $86.1 billion in 2012. BCC Research projects the market to grow to $112.1 billion by 2017, and register a five-year compound annual growth rate (CAGR) of 5.4% from 2012 to 2017.

 RSS Feeds – Pharmaceuticals

Use this report to:

  • Gain an overview of orphan drug criteria, the history of the Orphan Drug Act and its influence, advantages inherent in orphan drug designation, and future growth trends.
  • Analyze global market trends, with data from 2011 and 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Evaluate specific rare diseases for which orphan drugs exist.
  • Assess the most promising therapeutic areas in the market.
  • Examine an outline of legislation and regulation, including public and private agencies involved in support and development.
  • Review comprehensive company profiles of major players in the industry.
To order your copy of this report or to download the complimentary introduction chapter click here.

No comments:

Post a Comment

Bookmark and Share